Holdings of MPM BIOIMPACT LLC
35 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 54.7 % of the equity sleeve
Sector breakdown
- Health care 1.6 %
- Unattributed 98.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 88.4 %
- FR 10.4 %
- KY 1.2 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 32 | 1B $ | 88.37 % |
| 2 | FR | 2 | 120.9M $ | 10.42 % |
| 3 | KY | 1 | 14M $ | 1.21 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | DBV Technologies SA | 5,213,361 | 108.9M $ | |
| 2 | Cullinan Therapeutics Inc | 7,648,268 | 108.7M $ | |
| 3 | Aktis Oncology Inc | 4,835,872 | 86.5M $ | |
| 4 | Liquidia Corp | 1,405,158 | 53M $ | |
| 5 | Alumis Inc | 2,386,529 | 52.6M $ | |
| 6 | Edgewise Therapeutics Inc | 1,660,696 | 52.3M $ | |
| 7 | Revolution Medicines Inc | 506,776 | 49.3M $ | |
| 8 | Agios Pharmaceuticals Inc | 1,306,261 | 44.2M $ | |
| 9 | Corcept Therapeutics Inc | 985,700 | 39.7M $ | |
| 10 | Trevi Therapeutics Inc | 3,298,430 | 39.4M $ | |
| 11 | Dianthus Therapeutics Inc | 423,982 | 35.6M $ | |
| 12 | Travere Therapeutics Inc | 1,133,365 | 33.7M $ | |
| 13 | Evommune Inc | 1,455,863 | 33.5M $ | |
| 14 | Cytokinetics Inc | 500,000 | 33M $ | |
| 15 | Syndax Pharmaceuticals Inc | 1,340,733 | 31.3M $ | |
| 16 | Context Therapeutics Inc | 10,679,391 | 28M $ | |
| 17 | Forte Biosciences Inc | 1,000,682 | 25.9M $ | |
| 18 | Palvella Therapeutics Inc | 206,404 | 25.7M $ | |
| 19 | Dyne Therapeutics Inc | 1,408,152 | 25.5M $ | |
| 20 | Stoke Therapeutics Inc | 767,038 | 25M $ | |
| 21 | Corvus Pharmaceuticals Inc | 1,674,875 | 24.5M $ | |
| 22 | Relay Therapeutics Inc | 2,359,586 | 23.5M $ | |
| 23 | Tarsus Pharmaceuticals Inc | 329,750 | 23.1M $ | |
| 24 | ORIC Pharmaceuticals Inc | 1,803,945 | 22.9M $ | |
| 25 | Monte Rosa Therapeutics Inc | 1,176,928 | 19.4M $ | |
| 26 | Natera Inc | 93,074 | 18.6M $ | |
| 27 | Climb Bio Inc | 2,593,439 | 17.8M $ | |
| 28 | Arcutis Biotherapeutics Inc | 733,966 | 17.3M $ | |
| 29 | Zymeworks Inc | 565,249 | 14.2M $ | |
| 30 | Belite Bio Inc | 88,045 | 14M $ | |
| 31 | Viridian Therapeutics Inc | 649,873 | 12.7M $ | |
| 32 | Abivax SA | 107,268 | 11.9M $ | |
| 33 | Allogene Therapeutics Inc | 2,242,933 | 5.5M $ | |
| 34 | Aclaris Therapeutics Inc | 391,918 | 1.5M $ | |
| 35 | WEREWOLF THERAPEUTICS INC | 1,208,810 | 1M $ | |